PHARMACEUTICAL COMPOSITION FOR SUSTAINED RELEASE OF THE HMG-COA REDUCTASE INHIBITOR FLUVASTATIN
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
N/A
Issued Date -
Oct 16, 2003
app pub date -
Oct 24, 1997
filing date -
Oct 8, 1996
priority date (Note) -
Abandoned
status (Latency Note)
Importance
Abstract
The present invention relates to pharmaceutical compositions for sustained release comprising a water soluble salt of the HMG-CoA reductase inhibitor fluvastatin as active ingredient, said composition being selected from the group comprising matrix formulations, diffusion-controlled membrane coated formulations; and combinations thereof.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully